General Information
Revision date
2018-07-04
Product name
Crizotinib-d5
Chemical name
Crizotinib-d5
CAS No.
1395950-48-7
1.2.1 Relevant identified uses
To be used only for scientific research and development. Not for use in humans or animals
Emergency telephone
+1(416) 665-9696 between 0800-1700 (GMT-5
Icons in SDS
Company Information
company name
Toronto Research Chemicals
e-mail address of the competent person responsible for the Safety Data Sheet
orders.trc@lgcgroup.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317, H319, H341, H400
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
2.1/2.2 Classification of the Substance or Mixture and Label Elements
Classification according to GHS
According to EU Regulation 1272/2008 and US OSHA 1910.1200) Eye Damage/Irritation (Category 2A) Sensitisation, Skin (Category 1) Germ Cell Mutagenicity (Category 2) Hazardous to the Aquatic Environment, Acute Hazard (Category 1)
Hazard statements
Identification (According to EU Regulation 1272/2008 and US OSHA 1910.1200) H319 Causes serious eye irritation. H317 May cause an allergic skin reaction. H341 Suspected of causing genetic defects. H400 Very toxic to aquatic life.
Signal word
Warning
Precautionary statements
P201 Obtain special instructions before use. P264 Wash hands thoroughly after handling. P272 Contaminated work clothing should not be allowed out of the workplace. P273 Avoid release to the environment. P280 Wear protective gloves/protective clothing/eye protection/face protection. P302/P352 IF ON SKIN: Wash with plenty of soap and water P305/P351/P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and P333/P313 easy to do - continue rinsing. If skin irritation or rash occurs: Get medical advice/attention.
2.3 Other hazards
No data available.
